Amy Maxmen, Nature Magazine

Amy Maxmen

Nature Magazine

Contact Amy

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • Unknown
Past:
  • Nature Magazine
  • Scientific American
  • Pulitzer Center
  • WGBH News
  • WIRED
  • National Geographic

Past articles by Amy:

Are new Omicron subvariants a threat? Here's how scientists are keeping watch

In South Africa, a network of researchers are studying whether new lineages BA.4 and BA.5 escape immunity from COVID-19 vaccines and prior infections. → Read More

African clinical trial denied access to key COVID drug Paxlovid

Supply shortages and limits on research leave low- and middle-income countries struggling to access Pfizer’s COVID-19 antiviral. → Read More

Scientists struggle to probe COVID’s origins amid sparse data from China

Origin investigations typically take years, but some researchers say China is delaying the process for political reasons as international tensions rise. → Read More

Wuhan market was epicentre of pandemic’s start, studies suggest

Report authors say that the coronavirus SARS-CoV-2 jumped to people from animals sold at the market on two occasions in late 2019 — but some scientists want more definitive evidence. → Read More

Two scientists will replace disgraced US science adviser Eric Lander

Celebrated sociologist Alondra Nelson and genome leader Francis Collins will temporarily split Lander’s duties. → Read More

South African scientists copy Moderna’s COVID vaccine

Researchers at WHO’s technology transfer hub complete first step in a project aimed at building capacity for vaccine manufacturing in low- and middle-income countries. → Read More

Has Biden followed the science? What researchers say

As the US president’s first year in office ends, Nature assesses whether he’s kept his promise to make evidence-based decisions. → Read More

WHO chief Tedros looks guaranteed for re-election amid COVID pandemic

Tedros Adhanom Ghebreyesus is the only nominee to head the World Health Organization, a possible nod from countries on their approval of his pandemic leadership. → Read More

Omicron blindspots: why it’s hard to track coronavirus variants

Researchers are rapidly sequencing the genomes of virus samples worldwide, but shortcomings in the global surveillance system make the task a challenge. → Read More

World commits to a pandemic response pact: what's next

Following a failure to rein in COVID, world leaders begin shaping an accord to prevent future disasters — one that holds them accountable. → Read More

Hundreds of Scientists Weigh in on a High-Stakes U.S. Abortion Case

Studies suggest that a reversal of the landmark Roe v. Wade decision would be detrimental for many → Read More

WHO names researchers to reboot outbreak origin investigations

The group, called SAGO, will create a permanent framework for probing epidemics, and initiate the next phase of the COVID origins hunt. → Read More

US COVID origins report: researchers pleased with scientific approach

Intelligence investigation is inconclusive on virus’s origins, but finds SARS-CoV-2 wasn’t weaponized and unlikely to have been engineered. → Read More

Has COVID taught us anything about pandemic preparedness?

Researchers warn that plans to prevent the next global outbreak don’t consider the failures that have fuelled our current predicament. → Read More

COVID boosters for wealthy nations spark outrage

Nations short of vaccine should get first doses to curb the pandemic, researchers say. → Read More

The COVID lab-leak hypothesis: what scientists do and don’t know

Nature examines arguments that the coronavirus SARS-CoV-2 escaped from a lab in China, and the science behind them. → Read More

Divisive COVID ‘lab leak’ debate prompts dire warnings from researchers

Allegations that COVID escaped from a Chinese lab make it harder for nations to collaborate on ending the pandemic — and fuel online bullying, some scientists say. → Read More

In shock move, US backs waiving patents on COVID vaccines

The development from the Biden administration draws cheers from public-health researchers and ire from drugmakers. → Read More

One million coronavirus sequences: popular genome site hits mega milestone

Popular genome site GISAID’s impressive effort to understand the spread of COVID-19 has seen scientists upload sequences from most nations on Earth. → Read More

One million coronavirus sequences: popular genome site hits mega milestone

Popular genome site GISAID’s impressive effort to understand the spread of COVID-19 has seen scientists upload sequences from most nations on Earth. → Read More